Non-responders to multiple ranibizumab injections in treatment of exudative age-related macular degeneration and the effect of the switch treatment to aflibercept.

被引：0
|
作者：
Manethova, Katerina [1 ,2 ]
Ernest, Jan [1 ,2 ]
Nemec, Pavel [1 ,2 ]
Rejmont, Leos [1 ,2 ]
Folleco, Fredy Manolo [1 ,2 ]
机构：
[1] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic
[2] Mil Univ Hosp Prague, Prague, Czech Republic
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
549
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Aflibercept treatment for patients with exudative age-related macular degeneration who were incomplete responders to multiple ranibizumab injections (TURF trial)
    Wykoff, Charles C.
    Brown, David M.
    Maldonado, Maria E.
    Croft, Daniel E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (07) : 951 - 955
  • [2] Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
    Otsuji, Tsuyoshi
    Nagai, Yoshimi
    Sho, Kenichiro
    Tsumura, Akiko
    Koike, Naoko
    Tsuda, Mei
    Nishimura, Tetsuya
    Takahashi, Kanji
    CLINICAL OPHTHALMOLOGY, 2013, 7 : 1487 - 1490
  • [3] Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
    Garcia-Layana, Alfredo
    Figueroa, Marta S.
    Araiz, Javier
    Ruiz-Moreno, Jose M.
    Gomez-Ulla, Francisco
    Arias-Barquet, Luis
    Reiter, Nicholas
    DRUGS & AGING, 2015, 32 (10) : 797 - 807
  • [4] Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept
    Alfredo García-Layana
    Marta S. Figueroa
    Javier Araiz
    José M. Ruiz-Moreno
    Francisco Gómez-Ulla
    Luis Arias-Barquet
    Nicholas Reiter
    Drugs & Aging, 2015, 32 : 797 - 807
  • [5] Ranibizumab and aflibercept for the treatment of wet age-related macular degeneration
    Yazdi, Mohammad Hossein
    Faramarzi, Mohammad All
    Nikfar, Shekoufeh
    Falavarjani, Khalil Ghasemi
    Abdollahi, Mohammad
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (09) : 1349 - 1358
  • [6] DELAY IN RANIBIZUMAB INJECTIONS FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Wang, Bob
    Lake, Stewart
    Saha, Niladri
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 : 8 - +
  • [7] Aflibercept: A review of its effect on the treatment of exudative age-related macular degeneration
    Papadopoulos, Zois
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (04) : 368 - 378
  • [8] Intravitreal aflibercept treatment in eyes with exudative age-related macular degeneration following prior treatment with intravitreal ranibizumab
    Narayan, Daniel Sanju
    Muecke, James
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2015, 63 (11) : 832 - 836
  • [9] Effect of Aflibercept and Bevacizumab for Ranibizumab-Refractory Exudative Age-Related Macular Degeneration
    Kim, Bo Hee
    Seo, Young Seung
    Chung, Hum
    Heo, Jang Won
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [10] Tachyphylaxis during treatment of exudative age-related macular degeneration with aflibercept
    Chikako Hara
    Taku Wakabayashi
    Yoko Fukushima
    Kaori Sayanagi
    Ryo Kawasaki
    Shigeru Sato
    Hirokazu Sakaguchi
    Kohji Nishida
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2019, 257 : 2559 - 2569
12345